ImPACT Quick Test 1
ImPACT Quick Test 1, a cognitive assessment software (FDA Class II; FDA product code POM, Computerized Cognitive Assessment Aid For Concussion) made by ImPACT Applications, Inc., was cleared under FDA 510(k) K170551 on 21 Jun 2017 and listed in FDA GUDID on 31 Jul 2017 (UDI-DI 00864127000325); the registry lists it as not in commercial distribution (GUDID) as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00864127000325 | Date31 Jul 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK170551 | Date21 Jun 2017 | StatusActive |
Official records
- AccessGUDID record 00864127000325
- FDA 510(k) database K170551
From the FDA record
- Device description
- ImPACT Quick Test is intended for use as a computerized cognitive test to aid in the assessment of concussion in individuals ages 12-70
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K170551 decided 21 Jun 2017 Active
- FDA GUDID UDI-DI 00864127000325 listed 31 Jul 2017 Listed
Timeline
- Cleared FDA 510(k) K170551
- Listed FDA GUDID 00864127000325
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- ImPACT Quick Test
- Generic name
- Cognitive assessment software
- Model / reference
- 1
- Primary DI / UDI-DI
- 00864127000325
- 510(k) Number
- FDA product code
- POM
- GMDN term
- Cognitive assessment software
- Device class
- Class II
- Regulation number
- 882.1471
- GUDID distribution status
- Not in Commercial Distribution
Similar devices
Other devices filed under FDA product code POM (Computerized Cognitive Assessment Aid For Concussion).